FI40108C - Menetelmä labiilien antigeenisten virusvalmisteiden stabilisoimiseksi - Google Patents

Menetelmä labiilien antigeenisten virusvalmisteiden stabilisoimiseksi

Info

Publication number
FI40108C
FI40108C FI150063A FI150063A FI40108C FI 40108 C FI40108 C FI 40108C FI 150063 A FI150063 A FI 150063A FI 150063 A FI150063 A FI 150063A FI 40108 C FI40108 C FI 40108C
Authority
FI
Finland
Prior art keywords
viral preparations
antigenic viral
stabilizing labile
stabilizing
labile antigenic
Prior art date
Application number
FI150063A
Other languages
English (en)
Finnish (fi)
Other versions
FI40108B (show.php
Inventor
Rightsel Wilton Adair
Schuler Edward Emerson
Original Assignee
Parke Davis & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis & Co filed Critical Parke Davis & Co
Publication of FI40108B publication Critical patent/FI40108B/fi
Application granted granted Critical
Publication of FI40108C publication Critical patent/FI40108C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/165—Mumps or measles virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI150063A 1962-08-16 1963-08-01 Menetelmä labiilien antigeenisten virusvalmisteiden stabilisoimiseksi FI40108C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US217293A US3186908A (en) 1962-08-16 1962-08-16 Calcium lactobionate stabilization of labile antigenic virus vaccine materials

Publications (2)

Publication Number Publication Date
FI40108B FI40108B (show.php) 1968-06-28
FI40108C true FI40108C (fi) 1968-10-10

Family

ID=22810442

Family Applications (1)

Application Number Title Priority Date Filing Date
FI150063A FI40108C (fi) 1962-08-16 1963-08-01 Menetelmä labiilien antigeenisten virusvalmisteiden stabilisoimiseksi

Country Status (10)

Country Link
US (1) US3186908A (show.php)
BR (1) BR6351350D0 (show.php)
CH (1) CH412201A (show.php)
DE (1) DE1227615B (show.php)
DK (1) DK104193C (show.php)
ES (1) ES290512A1 (show.php)
FI (1) FI40108C (show.php)
FR (1) FR1594506A (show.php)
GB (1) GB1049386A (show.php)
SE (1) SE314774B (show.php)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4380582A (en) * 1965-07-09 1983-04-19 The United States Of America As Represented By The Secretary Of The Army Preparation of dry variola virus
DE1617457A1 (de) * 1966-12-16 1972-04-20 Erba Carlo Spa Verfahren zur Stabilisierung von Zubereitungen interferierender Virusprodukte
FR2076787A5 (en) * 1970-01-28 1971-10-15 Merieux Inst Lyophilisation stabiliser - for viruses contg potassium phosphate lactose and albumin
JPS5716823A (en) * 1980-07-03 1982-01-28 Green Cross Corp:The Live mumps vaccine pharmaceutical and stabilizing method
FR2505657A1 (fr) * 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
GB0218821D0 (en) * 2002-08-13 2002-09-18 Glaxosmithkline Biolog Sa Novel compositions
CN116115766B (zh) * 2023-02-06 2024-04-09 广东永顺生物制药股份有限公司 一种活疫苗耐热冻干保护剂及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA603832A (en) * 1960-08-23 J. Scott William Method and means for the dried storage of micro-organisms
US2186975A (en) * 1933-04-10 1940-01-16 Horace S Isbell Crystalline calcium lactobionate calcium bromide and process for making the same
GB716920A (en) * 1951-07-31 1954-10-20 Andre Jean Pierre Joseph Thoma A process for the mass production and treatment of pathogenic viruses and substances which accompany them
US2879202A (en) * 1954-11-05 1959-03-24 American Cyanamid Co Stabilization of live viral vaccines by hexahydric alcohols
US2912361A (en) * 1956-11-28 1959-11-10 Sterling Drug Inc Canine distemper vaccine and its preparation
US2946724A (en) * 1957-05-29 1960-07-26 American Cyanamid Co Stable poliomyelitis live virus vaccine
GB899011A (en) * 1958-03-14 1962-06-20 Upjohn Co Rubeola vaccine and process
US3031378A (en) * 1959-05-30 1962-04-24 Ishidate Morizo Method of inactivating viruses
GB900115A (en) * 1960-06-15 1962-07-04 Armour & Co Improvements in or relating to trypsin solutions

Also Published As

Publication number Publication date
DK104193C (da) 1966-04-18
FR1594506A (show.php) 1970-06-08
CH412201A (fr) 1966-04-30
DE1227615B (de) 1966-10-27
ES290512A1 (es) 1963-11-16
GB1049386A (en) 1966-11-23
SE314774B (show.php) 1969-09-15
FI40108B (show.php) 1968-06-28
BR6351350D0 (pt) 1973-08-02
US3186908A (en) 1965-06-01

Similar Documents

Publication Publication Date Title
CH397143A (fr) Filière
FI41830C (fi) Menetelmä uusien tetrakosapeptidien valmistamiseksi
CH397940A (fr) Filière
FR3041M (fr) Préparations vitaminiques.
BR6464845D0 (pt) Preparacoes praguicidas
DK104193C (da) Fremgangsmåde til stabilisering af labile, antigene virusmaterialer.
FR1354736A (fr) Repose-pieds perfectionné
FR1319432A (fr) Turbo-extracteur
CH396294A (fr) Filiére
CH396292A (fr) Filiére
FR1322406A (fr) Aérostat
NL139870B (nl) Werkwijze ter bereiding van insekticide preparaten.
FR2774M (fr) Vaccins antigenes somatiques.
BR6347168D0 (pt) Preparacao de vacina
FI47633C (fi) Menetelmä dispersioiden valmistamiseksi.
CH397144A (fr) Filière
FR1316603A (fr) Projecteur
FR1321612A (fr) Sièges symétriques
GR23362B (el) Ειδικος τροπος παρασκευης συκοπολτου.
FI40708C (fi) Menetelmä oksitetrasykliinin valmistamiseksi
GR23722B (el) Μεθοδος παρασκευης της θειενυλο - φαινυλο - αιθυλο (ν-μεθυλομορφολινιον) καρβινολης.
FI41546C (fi) Alfa-n propyyliamino-2-metyylipropionanilidin valmistustapa
SE219190C1 (sv) Sätt att framställa 17α-acyloxi-21-hydroxisteroider
CH438830A (de) Insektizide Zubereitungen
FR1366781A (fr) Aspirateur